CYFIP2 and gastric cancer: Jiao et al. reported CYFIP2 was a novel p53-mediated pro-apoptotic protein whose expression was decreased in gastric cancer and they showed CYFIP2 knockdown promoted proliferation and colony formation, and inhibited apoptosis in gastric cancer cells [29].